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Glycaemic index, breast and 
colorectal cancer
Glycaemic index (GI) is an extension of the fibre hypothesis
[1] and a ranking of carbohydrates based on their post-
prandial blood glucose response [2]. The basic concept is that
a higher rate of carbohydrate absorption leads to higher blood
glucose and insulin rise, and hence a higher GI index. GI has
been linked to non-insulin-dependent diabetes mellitus [3, 4],
coronary heart disease, and also to excess risk of colorectal [5]
and breast [6] cancer. Refined cereal intake has also been
related to elevated risk of oral, oesophageal and laryngeal [7],
and other digestive tract neoplasms [8]. The possible link is
related to mutagenic and perhaps promotional effects of
insulin and insulin-like growth factor (IGF) on the process of
carcinogenesis [9–11]. Available data on GI and cancer risk
are, however, extremely scanty. A multicentre case–control
study from Italy found an odds ratio (OR) of 1.7 for colorectal
cancer [5] and 1.4 for breast cancer [6] in the highest GI
quintile, with significant trends in risk.
To provide further information on the issue, we considered
data from two case–control studies on colorectal and breast
cancer conducted between 1992 and 2001 in the Swiss Canton
of Vaud [12, 13]. Cases were 323 patients (192 males,
131 females) with incident, histologically confirmed colon
(n = 169) or rectal (n = 154) cancer (median age 65 years), and
331 women with breast cancer (median age 58 years) admitted
to the University Hospital of Lausanne, Switzerland.
Controls were 1145 subjects (330 males, 815 females) aged
<75 years (median age 59 years) residing in the same geo-
graphical area and admitted to the same hospital as cases
for acute, non-neoplastic diseases (33% traumas, 31% non-
traumatic orthopaedic conditions, 19% surgical conditions and
17% miscellaneous other disorders). Sixteen percent of sub-
jects (17% of cases, 15% of controls) who were approached
for interview refused. The structured questionnaire included
information on socio-demographic characteristics and life-
style habits, and menstrual and hormonal factors for women.
A food-frequency questionnaire (FFQ) was used to assess
subjects’ habitual diet, including information on weekly fre-
quency of consumption of specific foods, as well as complex
recipes (79 items) during the 2 years prior to cancer diagnosis
or hospital admission (for controls).
GI was expressed as a percentage of the glycaemic response
elicited using white bread as a standard food. For each subject,
average daily GI was calculated by summing the products of
the carbohydrate content per serving, for each food or recipe,
times the average number of servings per week, times its GI,
all divided by the total amount of available weekly carbo-
hydrate intake. A score of the daily average glycaemic load
(GL) was computed as the GI, but without dividing by the total
amount of carbohydrates [14, 15]. ORs and the corresponding
95% confidence intervals (CI) were computed by tertile (of
the control distribution) of daily GI and GL score, using
Table 1. ORs and 95% CIsa of colorectal (323 cases, 611 controls) and breast cancer (331 cases, 534 controls) by tertile of 
energy-adjusted daily GI (Vaud, Switzerland, 1992–2001)
aAdjusted for age, sex, education, physical activity, number of daily meals, alcohol consumption, fibre and energy intake 
(colorectum), plus parity, menopausal status and oral contraceptive use (for breast cancer).
bReference category.
Cancer sites GI, tertile/OR (95% CI) χ21 (trend) P value
1b 2 3
Colorectum
Upper limit (controls) 74.4 85.7
Colon 1 2.85 (1.64–4.93) 2.35 (1.35–4.07) 6.63 0.01
Rectum 1 1.83 (1.09–3.07) 1.31 (0.76–2.25) 0.55 0.46
Colorectum 1 2.19 (1.45–3.31) 1.82 (1.19–2.78) 4.54 0.03
Breast
Upper limit (controls) 73.0 111.8
1 1.60 (1.05–2.43) 1.25 (0.83–1.87) 0.75 0.39
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unconditional multiple logistic regression models, including
terms for age, sex, education, occupational physical activity,
number of daily meals, alcohol and fibre intake, and total
energy intake according to the residual model [16] plus, for
breast cancer, parity, menopausal status and oral contracept-
ive use.
Table 1 gives the distribution of cases of colorectal and
breast cancer, and the corresponding controls, according to
dietary GI. Significantly elevated ORs were observed in the
second (OR 2.2) and third (OR 1.8) tertiles for colorectal
cancer. The association was apparently stronger for colon than
for rectal cancer, and the trends in risk were significant for
colon only and colorectum combined. For breast cancer, the
ORs for subsequent levels of GI were 1.6 and 1.3, and the
trend in risk was non-significant. No consistent relation was
observed between GL and colorectal or breast cancer risk.
Therefore, the results of this study, based on a validated
FFQ [12] and on large datasets, offer limited evidence for an
association between dietary GI and increased colorectal cancer
risk in Switzerland, in the absence, however, of a linear trend
in risk for both colorectal and breast cancer. They are conse-
quently only partly supportive of the findings of case–control
studies of colorectal [5] and breast [6] cancer conducted in
Italy.
The less consistent association observed in this Swiss
population, if not due to chance or bias, can be attributed to the
different composition of the Swiss diet, which includes a
lower proportion of energy from carbohydrates, and a greater
proportion of wholegrain cereals as compared with the Italian
diet [7, 17]. The comparatively high proportion of wholegrain
cereals [12, 13], which may have a favourable effect on colon
and breast cancer [8], may also explain the absence of associ-
ation with GL, which is a combination of quantity as well as
quality of carbohydrates consumed [2].
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